Trevena

Trevena

Trevena

Trevena is a clinical stage biopharmaceutical company discovering and developing G-protein coupled receptors (GPCR) biased ligands.
Founded
2007
Raised
$164M
Follow us
Alexa global traffic share
Twitter followers
05 Nov 2014
$45,000,000
Post-IPO equity
09 May 2013
$60,000,000
Venture capital (Series C)
14 Jul 2010
$35,000,000
Venture capital (Series B)
01 Mar 2008
$24,000,000
Venture capital (Series A)